Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 155

Sort by

Sort Order Select

Journal Articles

JAK2 -mutant clonal hematopoiesis is associated with venous thromboembolism

Rebecca L. Zon, Aswin Sekar, Katharine Clapham, Ohad Oren, Abhishek Niroula, Alexander G. Bick, Christopher J. Gibson, Gabriel Griffin, Md Mesbah Uddin, Donna Neuberg, Pradeep Natarajan, Benjamin L. Ebert

Blood (2024) 144 (20): 2149–2154.

https://doi.org/10.1182/blood.2024024187

Published: 2024

Includes: Supplemental data

Journal Articles

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Blood (2023) 141 (15): 1884–1888.

https://doi.org/10.1182/blood.2022017686

Published: 2023

Includes: Supplemental data

Journal Articles

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19

Blood (2022) 140 (18): 1993–1997.

https://doi.org/10.1182/blood.2022018052

Published: 2022

Includes: Supplemental data

Journal Articles

TET2 -mutant clonal hematopoiesis and risk of gout

Blood (2022) 140 (10): 1094–1103.

https://doi.org/10.1182/blood.2022015384

Published: 2022

Includes: Supplemental data

Journal Articles

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Peter G. Miller, Dandi Qiao, Joselyn Rojas-Quintero, Michael C. Honigberg, Adam S. Sperling, Christopher J. Gibson, Alexander G. Bick, Abhishek Niroula, Marie E. McConkey, Brittany Sandoval, Brian C. Miller, Weiwei Shi, Kaushik Viswanathan, Matthew Leventhal, Lillian Werner, Matthew Moll, Brian E. Cade, R. Graham Barr, Adolfo Correa, L. Adrienne Cupples, Sina A. Gharib, Deepti Jain, Stephanie M. Gogarten, Leslie A. Lange, Stephanie J. London, Ani Manichaikul, George T. O’Connor, Elizabeth C. Oelsner, Susan Redline, Stephen S. Rich, Jerome I. Rotter, Vasan Ramachandran, Bing Yu, Lynette Sholl, Donna Neuberg, Siddhartha Jaiswal, Bruce D. Levy, Caroline A. Owen, Pradeep Natarajan, Edwin K. Silverman, Peter van Galen, Yohannes Tesfaigzi, Michael H. Cho, Benjamin L. Ebert, for the COPDGene Study Investigators, National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine Consortium

Blood (2022) 139 (3): 357–368.

https://doi.org/10.1182/blood.2021013531

Published: 2022

Includes: Supplemental data

Journal Articles

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Blood (2021) 138 (10): 898–911.

https://doi.org/10.1182/blood.2021011075

Published: 2021

Includes: Supplemental data

Journal Articles

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Blood (2021) 137 (23): 3212–3217.

https://doi.org/10.1182/blood.2021010867

Published: 2021

Includes: Supplemental data

Journal Articles

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Blood (2021) 137 (10): 1353–1364.

https://doi.org/10.1182/blood.2020006464

Published: 2021

Includes: Supplemental data

Journal Articles

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Mikko Myllymäki, Robert Redd, Christopher R. Reilly, Wael Saber, Stephen R. Spellman, Christopher J. Gibson, Zhen-Huan Hu, Tao Wang, Esther H. Orr, Jaclyn G. Grenier, Maxine M. Chen, David P. Steensma, Corey Cutler, Immaculata De Vivo, Joseph H. Antin, Donna Neuberg, Suneet Agarwal, R. Coleman Lindsley

Blood (2020) 136 (26): 3070–3081.

https://doi.org/10.1182/blood.2020005397

Published: 2020

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve Settings

Blood (2020) 136 (Supplement 1): 15–17.

https://doi.org/10.1182/blood-2020-136235

Published: 2020

Journal Articles

SF3B1 -mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

Blood (2020) 136 (2): 157–170.

https://doi.org/10.1182/blood.2020004850

Published: 2020

Journal Articles

Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma

Jeremy S. Abramson, Jon E. Arnason, Ann S. LaCasce, Robert Redd, Jeffrey A. Barnes, Lubomir Sokol, Robin Joyce, David Avigan, Donna Neuberg, Ronald W. Takvorian, Ephraim P. Hochberg, Celeste M. Bello

Blood (2019) 134 (7): 606–613.

https://doi.org/10.1182/blood.2019001272

Published: 2019

Includes: Supplemental data

Journal Articles

Plateletpheresis-associated lymphopenia in frequent platelet donors

Blood (2019) 133 (6): 605–614.

https://doi.org/10.1182/blood-2018-09-873125

Published: 2019

Includes: Supplemental data

Journal Articles

A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens

Blood (2018) 132 (18): 1911–1921.

https://doi.org/10.1182/blood-2018-04-843763

Published: 2018

Includes: Supplemental data

Journal Articles

Mass cytometry of Hodgkin lymphoma reveals a CD4 + regulatory T-cell–rich and exhausted T-effector microenvironment

Fathima Zumla Cader, Ron C. J. Schackmann, Xihao Hu, Kirsty Wienand, Robert Redd, Bjoern Chapuy, Jing Ouyang, Nicole Paul, Evisa Gjini, Mikel Lipschitz, Philippe Armand, David Wu, Jonathan R. Fromm, Donna Neuberg, X. Shirley Liu, Scott J. Rodig, Margaret A. Shipp

Blood (2018) 132 (8): 825–836.

https://doi.org/10.1182/blood-2018-04-843714

Published: 2018

Includes: Multimedia, Supplemental data

Journal Articles

Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma

Christopher D. Carey, Daniel Gusenleitner, Mikel Lipschitz, Margaretha G. M. Roemer, Edward C. Stack, Evisa Gjini, Xihao Hu, Robert Redd, Gordon J. Freeman, Donna Neuberg, F. Stephen Hodi, Xiaole Shirley Liu, Margaret A. Shipp, Scott J. Rodig

Blood (2017) 130 (22): 2420–2430.

https://doi.org/10.1182/blood-2017-03-770719

Published: 2017

Includes: Supplemental data

Journal Articles

Response: Making “perfect” the enemy of good

Jason E. Farrar, Donna Neuberg, Timothy Triche, Jr, David M. Bodine

Blood (2017) 130 (9): 1168–1169.

https://doi.org/10.1182/blood-2017-07-789107

Published: 2017

Journal Articles

Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin

Charlene Mantia, Erik J. Uhlmann, Maneka Puligandla, Griffin M. Weber, Donna Neuberg, Jeffrey I. Zwicker

Blood (2017) 129 (25): 3379–3385.

https://doi.org/10.1182/blood-2017-02-767285

Published: 2017

Journal Articles

Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

Blood (2016) 128 (14): 1845–1853.

https://doi.org/10.1182/blood-2015-07-660506

Published: 2016

Includes: Supplemental data

Journal Articles

DC/Aml Fusion Cell Vaccination Administered to AML Patients Who Achieve a Complete Remission Potently Expands Leukemia Reactive T Cells and Is Associated with Durable Remissions

Blood (2015) 126 (23): 2549.

https://doi.org/10.1182/blood.V126.23.2549.2549

Published: 2015

NARROW

JAK2 -mutant clonal hematopoiesis is associated with venous thromboembolism

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19

TET2 -mutant clonal hematopoiesis and risk of gout

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve Settings

SF3B1 -mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma

Plateletpheresis-associated lymphopenia in frequent platelet donors

A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens

Mass cytometry of Hodgkin lymphoma reveals a CD4 + regulatory T-cell–rich and exhausted T-effector microenvironment

Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma

Response: Making “perfect” the enemy of good

Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin

Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

DC/Aml Fusion Cell Vaccination Administered to AML Patients Who Achieve a Complete Remission Potently Expands Leukemia Reactive T Cells and Is Associated with Durable Remissions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only